Key facts
- This page summarizes David V Smith's Form 3 filing for IO Biotech, Inc. (IOBT).
- 0 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 03 Mar 2022, 15:15.
David V Smith - 01 Mar 2022 Form 3 Insider Report for IO Biotech, Inc. (IOBT)
- Role
- Director
- Signature
- /s/ Brian Burkavage, Attorney-in-Fact for David V. Smith
- Issuer symbol
- IOBT
- Transactions as of
- 01 Mar 2022
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 03 Mar 2022, 15:15:30 UTC
- Previous filing
- 14 Jan 2022
- Next filing
- 31 May 2022
- SEC
- View on sec.gov
Key filing fact
David V Smith filed Form 3 for IO Biotech, Inc. (IOBT) on 03 Mar 2022.
Change
- Previous filing in this sequence was filed on 14 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC Source
See Original Filing
Ownership activity is grounded in SEC Form 3 disclosures.
No securities are beneficially owned.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney